Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relaxin in Acute Heart Failure
NCT00520806Phase 3Completed
- Start
- Oct 2007
- Primary completion
- Sep 2012
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of serelaxin in Acute Heart Failure (AHF). Started Oct 2007; status: completed.
02
Drugs
serelaxin
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on NCT00520806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00520806.